View all news

    European Commission Approves Symtuza® for the Treatment of HIV-1 In Adults and Adolescents in Europe

    09/26/2017
    Download(opens in new window)PDF 91 KB

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com